Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption

Journal of Bone and Mineral Research

Volumn 15, Issue 12, 2000, Pages 2293-2296

  Riggs, B L ^a   Baron, R ^a   Boyle, W J ^a   Drezner, M ^a   Manolagas, S ^a   Martin, T J ^a   Stewart, A F ^a   Suda, T ^a   Yasuda, H ^a   Aubin, J ^a   Goltzman, D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Osteoclast differentiation and activation receptor; Osteoclast differentiation factor; Osteoclastogenesis inhibitory factor; Tumor necrosis factor related activation induced cytokine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NOMENCLATURE; OSTEOLYSIS; SIGNAL TRANSDUCTION;

BONE RESORPTION; CARRIER PROTEINS; GLYCOPROTEINS; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TERMINOLOGY; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033711760     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.12.2293     Document Type: Article

References (19)

1. Advances in bone biology: The osteoclast
2. Modulation of osteoclast differentiation: Update 1995
3. Interleukins in the control of osteoclast differentiation
4. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone
5. The bone marrow-derived stromal cell lines MC3T3/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
6. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
7. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
8. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
9. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
10. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
11. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
12. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
14. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
15. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
16. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
17. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
18. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand